Acute promyelocytic leukemia (APL) accounts for roughly 5–8% of patients with acute myeloid leukemia (AML) and is characterized by the balanced translocation t(15;17)(q22;q12), resulting in the fusion transcript PML-RARA [1]. Here, RARA is linked to acute promyelocytic leukemia.